Race and Ethnicity are Associated with Delays in Breast Cancer Treatment (2003-2006)
Race and Ethnicity are Associated with Delays in Breast Cancer Treatment (2003-2006)
复制标题
DOI：
10.1353/hpu.2011.0006
复制
发表时间：
2011-02-01
影响因子：
1.4
通讯作者：
Ward, Elizabeth M.
中科院分区：
文献类型：
--
作者：
Fedewa, Stacey A.;Edge, Stephen B.;Ward, Elizabeth M.
获得及时治疗可能是乳腺癌患者中种族/民族生存差异的一个促成因素。在这项研究中，我们研究了2003年至2006年期间诊断为国家癌症数据库（n= 250，007）中I-III期乳腺癌的乳腺癌患者中种族与治疗延迟之间的关系。我们使用多变量对数二项模型评估了与活检后超过30、60和90天接受初始治疗相关的因素，以估计风险比（RR）和95%置信区间（CI）。至治疗的平均时间为34.30天（+/- 31.77）。与健康保险、诊断时的分期和年龄无关，与白色患者相比，黑人和西班牙裔患者有更高的30、60和90天治疗延迟的风险。需要进一步研究，以确定结构，卫生系统，医生，临床和患者因素在黑人和西班牙裔妇女和适当的干预措施之间的治疗延迟的作用。
Access to timely treatment may be one contributing factor to survival differences by race/ethnicity among breast cancer patients. In this study, we examined the relationship between race and treatment delay among breast cancer patients diagnosed between 2003 and 2006 with Stage I-III breast cancer from the National Cancer Database (n=250,007). We evaluated factors associated with receipt of initial treatment more than 30, 60, and 90 days after biopsy using multivariable log binomial models to estimate risk ratios (RR) and 95% confidence intervals (CI). The average time to treatment was 34.30 days (+/- 31.77). Independent of health insurance, stage at diagnosis, and age, Black and Hispanic patients had higher risks of 30, 60, and 90-day treatment delay compared with White patients. Further studies are needed to define the role of structural, health system, physician, clinical and patient factors in treatment delay among Black and Hispanic women and appropriate interventions.